Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak

References

1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020.  https://doi.org/10.1038/s41586-020-2012-7  PMID: 32015507 
2. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;NEJMoa2001316.  PMID: 31995857 
3. Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020;25(3):25.  https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000044  PMID: 31992388 
4. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;S0140-6736(20)30260-9.  PMID: 32014114 
5. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill. 2020;25(5):2000062.  https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062 
6. Cohen E. China says coronavirus can spread before symptoms show -- calling into question US containment strategy. Atlanta: CNN. [Accessed 4 Feb 2020]. Available from: https://edition.cnn.com/2020/01/26/health/coronavirus-spread-symptoms-chinese-officials/index.html
7. Pitzer VE, Leung GM, Lipsitch M. Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China. Am J Epidemiol. 2007;166(3):355-63.  https://doi.org/10.1093/aje/kwm082  PMID: 17493952 
8. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767-72.  https://doi.org/10.1016/S0140-6736(03)13412-5  PMID: 12781535 
9. Ip DKM, Lau LLH, Chan KH, Fang VJ, Leung GM, Peiris MJS, et al. The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections. Clin Infect Dis. 2016;62(4):431-7. PMID: 26518469 
10. Tellier R, Li Y, Cowling BJ, Tang JW. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis. 2019;19(1):101.  https://doi.org/10.1186/s12879-019-3707-y  PMID: 30704406 
11. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, et al. , SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361(9366):1319-25.  https://doi.org/10.1016/S0140-6736(03)13077-2  PMID: 12711465 
12. Zhou J, Li C, Zhao G, Chu H, Wang D, Yan HH, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv. 2017;3(11):eaao4966.  https://doi.org/10.1126/sciadv.aao4966  PMID: 29152574 
13. Yu IT, Qiu H, Tse LA, Wong TW. Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy. Clin Infect Dis. 2014;58(5):683-6.  https://doi.org/10.1093/cid/cit797  PMID: 24319085 
14. Swift R. Sixty more people confirmed with coronavirus on cruise ship in Japan: media. Tokyo: Reuters. [Accessed 10 Feb 2020]. Available from: https://www.reuters.com/article/us-china-health-japan/sixty-more-people-confirmed-with-coronavirus-on-cruise-ship-in-japan-media-idUSKBN2040FG
15. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;S0140-6736(20)30183-5. (Forthcoming).  PMID: 31986264 
16. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;S0140-6736(20)30211-7.  PMID: 32007143 
17. Choe PG, Perera RAPM, Park WB, Song KH, Bang JH, Kim ES, et al. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Emerg Infect Dis. 2017;23(7):1079-84.  https://doi.org/10.3201/eid2307.170310  PMID: 28585916 
18. Kam YW, Kien F, Roberts A, Cheung YC, Lamirande EW, Vogel L, et al. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Vaccine. 2007;25(4):729-40.  https://doi.org/10.1016/j.vaccine.2006.08.011  PMID: 17049691 
19. Wang SF, Tseng SP, Yen CH, Yang JY, Tsao CH, Shen CW, et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem Biophys Res Commun. 2014;451(2):208-14.  https://doi.org/10.1016/j.bbrc.2014.07.090  PMID: 25073113 
20. Ryu S, Gao H, Wong JY, Shiu EYC, Xiao J, Fong MW, et al. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures. Emerg Infect Dis. 2020;26(5):26.  https://doi.org/10.3201/eid2605.190993  PMID: 32027587 
21. Fong MW, Gao H, Wong JY, Xiao J, Shiu EYC, Ryu S, et al. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing Measures. Emerg Infect Dis. 2020;26(5):26.  https://doi.org/10.3201/eid2605.190995  PMID: 32027585 
22. Bootsma MC, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci USA. 2007;104(18):7588-93.  https://doi.org/10.1073/pnas.0611071104  PMID: 17416677 
23. Reusken CBEM, Broberg EK, Haagmans B, Meijer A, Corman VM, Papa A, et al. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 European Union/European Economic Area countries, January 2020. Euro Surveill. 2020;25(6).